1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Improved Prognosis of Hypoplastic Left Heart: A Population-Based Register Study of 343 Cases in England and Wales

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Hypoplastic Left Heart Syndrome (HLHS) is a severe congenital heart defect (CHD) characterised by the underdevelopment of the left side of the heart with varying levels of hypoplasia of the left atrium, mitral valve, left ventricle, aortic valve and aortic arch. In the UK, age 12 survival for cases born between 1991 and 1993 was 21%. UK survival estimates corresponding to cases born between 2000 and 2015 were improved at 56%, but survival was examined up to age five only. Contemporary long-term survival estimates play a crucial role in counselling parents following diagnosis. The aim of this study was to report survival estimates up to age 15 for children born with HLHS or hypoplastic left ventricle with additional CHD in England and Wales between 1998 and 2012.

          Methods: Cases of HLHS notified to four congenital anomaly registers in England and Wales during 1998–2012, matched to Office for National Statistics mortality information, were included. Kaplan-Meier survival estimates to age 15 were reported. Cox regression models were fitted to examine risk factors for mortality.

          Results: There were 244 cases of HLHS and 99 cases of hypoplastic left ventricle co-occurring with other CHD, with traced survival status. Kaplan-Meier survival estimates for HLHS were 84.4% at age 1 week, 76.2% at 1 month, 63.5% at age 1 year, 58.6% at age 5 years, 54.6% at age 10 years, and 32.6% to age 15 years. The Kaplan-Meier survival estimates for cases of hypoplastic left ventricle co-occurring with additional CHD were 90.9% at age 1 week, 84.9% at 1 month, 73.7% at age 1 year, 67.7% to age 5 years, 59.2% to age 10 years, and 40.3% to age 15 years. Preterm birth ( p = 0.007), low birth weight ( p = 0.005), and female sex ( p = 0.01) were associated with mortality.

          Conclusions: We have shown that prognosis associated with HLHS in the twenty first century exceeds that of many previous population-based studies, likely due to improvements in intensive care technologies and advances in surgical techniques over the last few decades.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: not found
          • Article: not found

          Measuring multiple deprivation at the small-area level

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Physiologic repair of aortic atresia-hypoplastic left heart syndrome.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Long‐Term Survival of Individuals Born With Congenital Heart Disease: A Systematic Review and Meta‐Analysis

              Background Estimates of long‐term survival are required to adequately assess the variety of health and social services required by those with congenital heart disease (CHD) throughout their lives. Methods and Results Medline, Embase, and Scopus were searched from inception to June 2015 using MeSH headings and keywords. Population‐based studies that ascertained all persons born with CHD within a predefined area and reported survival estimates at ≥5 years were included. Unadjusted survival estimates for each CHD subtype at ages 1 year, 5 years, 10 years, and so forth were extracted. Pooled survival estimates for each age were calculated using meta‐analyses. Metaregression was performed to examine the impact of study period on survival. Of 7840 identified articles, 16 met the inclusion criteria. Among those with CHD, pooled 1‐year survival was 87.0% (95% CI 82.1–91.2), pooled 5‐year survival was 85.4% (95% CI 79.4–90.5), and pooled 10‐year survival was 81.4% (95% CI 73.8–87.9). There was significant heterogeneity of survival estimates among articles (P<0.001 for 1‐, 5‐, and 10‐year survival). A more recent study period was significantly associated with greater survival at ages 1 year (P=0.047), 5 years (P=0.013), and 10 years (P=0.046). Survival varied by CHD subtype, with 5‐year survival being greatest for those with ventricular septal defect (96.3%, 95% CI 93.7–98.2) and lowest for those with hypoplastic left heart (12.5%, 95% CI 0.0–41.4). Conclusions Among persons with CHD, the mortality rate is greatest during the first year of life; however, this systematic review and meta‐analysis showed that survival decreases gradually after infancy and into adulthood.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pediatr
                Front Pediatr
                Front. Pediatr.
                Frontiers in Pediatrics
                Frontiers Media S.A.
                2296-2360
                06 July 2021
                2021
                : 9
                : 635776
                Affiliations
                [1] 1Population Health Sciences Institute, Newcastle University , Newcastle upon Tyne, United Kingdom
                [2] 2Leeds Institute of Health Sciences, University of Leeds , Leeds, United Kingdom
                [3] 3Public Health England National Congenital Anomaly and Rare Disease Registration Service , London, United Kingdom
                [4] 4Department of Health Sciences, University of Leicester , Leicester, United Kingdom
                [5] 5Congenital Anomaly Register and Information Service , Swansea, United Kingdom
                [6] 6Bristol Medical School, University of Bristol , Bristol, United Kingdom
                Author notes

                Edited by: Babak Khoshnood, INSERM U1153 Centre de Recherche Épidémiologie et Statistique, France

                Reviewed by: Diala Khraiche, Assistance Publique Hopitaux De Paris, France; Neil Derridj, Institut National de la Santé et de la Recherche Médicale (INSERM), France

                *Correspondence: Judith Rankin judith.rankin@ 123456ncl.ac.uk

                This article was submitted to General Pediatrics and Pediatric Emergency Care, a section of the journal Frontiers in Pediatrics

                Article
                10.3389/fped.2021.635776
                8289898
                34295856
                2ec2bf89-c269-4224-a156-427a73c8104c
                Copyright © 2021 Best, Miller, Draper, Tucker, Luyt and Rankin.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 30 November 2020
                : 17 May 2021
                Page count
                Figures: 2, Tables: 3, Equations: 0, References: 36, Pages: 9, Words: 7058
                Categories
                Pediatrics
                Original Research

                congenital heart,hypoplastic left heart,survival,epidemiology,register,congenital anomalies

                Comments

                Comment on this article